Abstract | BACKGROUND: METHODS: A retrospective study was conducted and enrolled pediatric ADEM patients who underwent serum MOG antibody detection from May 2017 to August 2020. The patients were divided into two groups: MOG- immunoglobulin G ( IgG) positive (n = 35) and MOG- IgG negative (n = 50). We analyzed the clinical characteristics of MOG- IgG-positive ADEM pediatric patients and conducted a comparative analysis between the two groups. RESULTS: Thirty-five patients (21 males and 14 females) in the MOG- IgG-positive group with encephalopathy, multifocal neurological symptoms, and typical magnetic resonance imaging (MRI) abnormalities were enrolled. They usually had a favorable outcome, while some suffered from relapse. Compared to the MOG- IgG-negative group, MOG- IgG-positive ADEM patients had a longer disease duration (median: 10 vs. 6 days), more meningeal involvement (31.4% vs. 8%) and frontal lobe involvement (82.8% vs. 68%), higher relapse rates (14.3% vs. 2%), lower serum tumor necrosis factor (1-12.4 pg/ml, median 1.7 vs. 1-34 pg/ml, median 2.2) and interferon-gamma (1-9.4 pg/ml, median 1.3 vs. 1-64 pg/ml, median 3) (P < 0.05, respectively). Multivariate logistic regression analysis showed that the longer disease duration, meningeal involvement and frontal lobe involvement were the correlated factors of patients with ADEM with MOG antibody (P < 0.05). CONCLUSIONS: Our findings provide clinical evidence that MOG- IgG positivity is associated with longer disease duration, meningeal involvement, and frontal lobe involvement.
|
Authors | Jue Shen, Donghui Lin, Tiejia Jiang, Feng Gao, Kewen Jiang |
Journal | BMC neurology
(BMC Neurol)
Vol. 22
Issue 1
Pg. 418
(Nov 09 2022)
ISSN: 1471-2377 [Electronic] England |
PMID | 36352355
(Publication Type: Journal Article)
|
Copyright | © 2022. The Author(s). |
Chemical References |
- Myelin-Oligodendrocyte Glycoprotein
- Autoantibodies
- Immunoglobulin G
|
Topics |
- Male
- Female
- Humans
- Myelin-Oligodendrocyte Glycoprotein
- Retrospective Studies
- Autoantibodies
- Encephalomyelitis, Acute Disseminated
- Immunoglobulin G
- Recurrence
|